Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion

We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing stocks on Friday.

Veracyte grew its share price by 7.04 percent on Friday to close at $25.25 apiece following announcements that it was set to join the S&P SmallCap 600 beginning on Tuesday, July 29.

This followed the removal of the Triumph Group following its planned merger with Warburg Pincus LLC and Berkshire Partners LLC.

Companies joining market indices typically see their share prices rise as investment firms begin adding them to the portfolios tracking the said indices. Additionally, index memberships bolster a stock’s visibility among institutional and retail investors.

In other news, Veracyte, Inc. (NASDAQ:VCYT) said that it will announce the results of its financial and operating highlights for the second quarter of the year after market close on August 6. A conference call will be held at 4:30 PM to discuss more details about the performance.

Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion

Photo by National Cancer Institute on Unsplash

Veracyte, Inc. (NASDAQ:VCYT) is a global diagnostics company seeking to advance and transform cancer care for patients all over the world.

While we acknowledge the risk and potential of VCYT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than VCYT and that has 10,000% upside potential, check out our report about this cheapest AI stock.